ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Clinical trial NCT06026332 · TERMINATED
Trial details
- NCT number
- NCT06026332
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-15
- Primary completion
- 2026-01-15
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.